Starpharma Holdings Ltd banner

Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.405 AUD 1.25% Market Closed
Market Cap: AU$169.4m

Wall Street
Price Targets

SPL Price Targets Summary
Starpharma Holdings Ltd

Wall Street analysts forecast SPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPL is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.

Lowest
Price Target
0.556 AUD
37% Upside
Average
Price Target
0.561 AUD
39% Upside
Highest
Price Target
0.578 AUD
43% Upside
Starpharma Holdings Ltd Competitors:
Price Targets
BTDR
Bitdeer Technologies Group
121% Upside
FCBC
First Community Bankshares Inc
-6% Downside

Revenue
Forecast

4% / Year
Past Growth
86% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
4% / Year
Past Growth
86% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

For the last 14 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 4%. The projected CAGR for the next 3 years is 86%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPL's stock price target?
Price Target
0.561 AUD

According to Wall Street analysts, the average 1-year price target for SPL is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.

What is Starpharma Holdings Ltd's Revenue forecast?
Projected CAGR
86%

For the last 14 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 4%. The projected CAGR for the next 3 years is 86%.

Back to Top